My 53‑year‑old female inpatient with acute ischemic stroke: among females 48–58, compare complexity score, percentile, LOS, and mortality for those with CYP3A4 interactions affecting NTI drugs versus the age‑matched cohort; report LOS and mortality for stroke patients in the top quartile.
